During the investigation of the molecular mechanism underlying EMMPRIN promoting breast cancer stem-like cells, SUM102 and BT474 cells were treated with human recombinant EMMPRIN (hrEMMPRIN) and we found that STAT3 was activated (Fig. 4A). The gene discussed is BSG; the disease is breast cancer.